Effect of the pharmacist-managed cardiovascular risk reduction services on diabetic retinopathy outcome measures | Zendy

Zach Weber | Zendy; Palakpreet Kaur | Zendy; Amrita Hundal | Zendy; Somnooma H. Ibriga | Zendy; Ashay D. Bhatwadekar | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of the pharmacist-managed cardiovascular risk reduction services on diabetic retinopathy outcome measures

Author(s) -

Zach Weber,

Palakpreet Kaur,

Amrita Hundal,

Somnooma H. Ibriga,

Ashay D. Bhatwadekar

Publication year - 2019

Publication title -

pharmacy practice

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.608

H-Index - 24

eISSN - 1886-3655

pISSN - 1885-642X

DOI - 10.18549/pharmpract.2019.1.1319

Subject(s) - medicine , diabetic retinopathy , pharmacist , diabetes mellitus , intervention (counseling) , retinopathy , medical record , clinical pharmacy , disease , pharmacy , retrospective cohort study , family medicine , intensive care medicine , emergency medicine , nursing , endocrinology

Our studies provide a proof-of-concept that pharmacists-managed care possesses a potential role in protection from DR, and paves a way for future pharmacists managed care with an emphasis on reducing diabetic complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research